HCPLive
American College of Cardiology ACC.13

American College of Cardiology ACC.13 | ACC 2013

According to the American College of Cardiology, the focus at ACC.13 will be on "the transformation of cardiovascular care — from discovery to delivery." Educational content at ACC.13 will be organized in 16 "learning pathways" that feature "topics ranging from congenital to intervention, imaging to heart failure, prevention to quality care and all the topics in between."

Conference Coverages

VIDEO: Worldwide SHIFT Study Trumps Predecessors on Link Between Heart Rate, Heart Failure Success
VIDEO: Worldwide SHIFT Study Trumps Predecessors on Link Between Heart Rate, Heart Failure Success
Jeffrey S. Borer, MD, of the Howard Gilman Institute for Heart Valve Disease, discusses the SHIFT study's value for cardiologists over various recent heart failure trials.
VIDEO: Beta Blocker Tolerability, Efficacy Key in Selection, But Vary Across Drugs
Jeffrey S. Borer, MD, of the Howard Gilman Institute for Heart Valve Disease, discusses the factors cardiologists consider in selecting specific beta blockers for heart failure patients.
Transcatheter Aortic Valve Replacement Is an Effective Alternative to Surgical Replacement
Data from the PARTNER cohort A trial show transcatheter aortic valve replacement produces similar mortality rates at one year compared with the standard procedure.
Off-Pump Coronary Artery Bypass Graft Is Associated with Similar Outcomes at One Year as On-Pump Surgery in Patients with Coronary Artery Disease
Results from the CORONARY trial show no significant difference at one year between patients with CAD who underwent on-pump vs. off-pump CABG.
Aliskiren Provides No Benefit as Add-on Therapy for Patients Hospitalized with Heart Failure
Results from the ASTRONAUT trial show that adding aliskiren to standard therapy for chronic heart failure does not improve mortality or rehospitalization rates.
VIDEO: Many Heart Failure Patients Cannot Tolerate Recommended Doses of Beta Blockers
Jeffrey S. Borer, MD, of the Howard Gilman Institute for Heart Valve Disease, discusses treating patients with heart failure with beta-blockers and whether there are any patients in this group who are not good candidates for this treatment.
Double Kissing Crush Stent Technique Produces Better Outcomes than Culotte Stenting in Patients with Coronary Artery Disease
Study results presented at ACC.13 show that patients with unprotected left main coronary artery disease treated with double kissing crush stenting experienced fewer cases of restenosis and other major adverse events compared to patients who received culotte stenting.
Modern Technology Reveals Atherosclerosis Was Prevalent in Ancient Populations
Investigators in the expanded HORUS trial using CT scans of ancient mummies from multiple populations and geographic regions report finding evidence of probable or definite atherosclerosis in nearly one-third of samples.
New Version of Sapien Transcatheter Aortic Valve Replacement System Produces Improved Outcomes Compared to Original Version
Results from the PARTNER II trial show improvements in 30-day mortality and stroke rates in patients with aortic stenosis who are not surgical candidates who were treated using a newer version of the Sapien transcatheter aortic valve replacement system.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$